Sujets)
Betacoronavirus , Infections à coronavirus , Maladie grave , Pandémies , Pneumopathie virale , /complications , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , COVID-19 , Comorbidité , Infections à coronavirus/sang , Infections à coronavirus/complications , Infections à coronavirus/mortalité , Infections à coronavirus/thérapie , Femelle , Hospitalisation , Humains , Unités de soins intensifs , Mâle , Adulte d'âge moyen , Pneumopathie virale/sang , Pneumopathie virale/complications , Pneumopathie virale/mortalité , Pneumopathie virale/thérapie , Ventilation artificielle , SARS-CoV-2 , Résultat thérapeutique , WashingtonRésumé
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been associated with multiple direct and indirect cardiovascular complications. We sought to analyze the association of host co-morbidities (chronic respiratory illnesses, cardiovascular disease [CVD], hypertension or diabetes mellitus [DM]) with the acute cardiovascular complications associated with SARS-CoV-2 infection. Individual analyses of the majority of studies found median age was higher by ~10 years in patients with cardiovascular complications. Pooled analyses showed development of SARS-CoV-2 cardiovascular complications was significantly increased in patients with chronic respiratory illness (odds ratio (OR): 1.67 [1.48, 1.88]), CVD (OR: 3.37 [2.57, 4.43]), hypertension (OR: 2.68 [2.11, 3.41]), DM (OR: 1.60 [1.31, 1.95]) and male sex (OR: 1.31 [1.21, 1.42]), findings that were mostly conserved during sub-analysis of studies stratified into global geographic regions. Age, chronic respiratory illness, CVD, hypertension, DM, and male sex may represent prognostic factors for the development of cardiovascular complications in COVID-19 disease, highlighting the need for a multidisciplinary approach to chronic disease patient management.